In a breast cancer model, CXCL1/2 is produced by cancer cells and serves as a chemoattractant for myeloid cells that are recruited to the lungs, where they produce S100A8/9 to enhance cancer cell survival at the metastatic site. This evidence concerns the gene S100A8 and cancer.